Evidence for Altered Metabolism of Sphingosine-1-Phosphate in the Corpus Callosum of Patients with Schizophrenia
Open Access
- 29 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 46 (5), 1172-1181
- https://doi.org/10.1093/schbul/sbaa052
Abstract
The disturbed integrity of myelin and white matter, along with dysregulation of the lipid metabolism, may be involved in schizophrenia pathophysiology. Considering the crucial role of sphingolipids in neurodevelopment, particularly in oligodendrocyte differentiation and myelination, we examined the role of sphingolipid dynamics in the pathophysiology of schizophrenia. We performed targeted mass spectrometry-based analysis of sphingolipids from the cortical area and corpus callosum of postmortem brain samples from patients with schizophrenia and controls. We observed lower sphingosine-1-phosphate (S1P) levels, specifically in the corpus callosum of patients with schizophrenia, but not in major depressive disorder or bipolar disorder, when compared with the controls. Patient data and animal studies showed that antipsychotic intake did not contribute to the lowered S1P levels. We also found that lowered S1P levels in the corpus callosum of patients with schizophrenia may stem from the upregulation of genes for S1P-degrading enzymes; higher expression of genes for S1P receptors suggested a potential compensatory mechanism for the lowered S1P levels. A higher ratio of the sum of sphingosine and ceramide to S1P, which can induce apoptosis and cell-cycle arrest, was also observed in the samples of patients with schizophrenia than in controls. These results suggest that an altered S1P metabolism may underlie the deficits in oligodendrocyte differentiation and myelin formation, leading to the structural and molecular abnormalities of white matter reported in schizophrenia. Our findings may pave the way toward a novel therapeutic strategy.Keywords
Funding Information
- Japan Society for the Promotion of Science (15K19754, 18K15501)
- Grant-in-Aid for Scientific Research on Innovative Areas
- Ministry of Education, Culture, Sports, Science and Technology (JP19H05435)
- Japan Agency for Medical Research and Development (JP19gm0910004)
- Strategic Research Program for Brain Sciences (JP19dm0107083)
This publication has 60 references indexed in Scilit:
- Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of SphingolipidomicsChemical Reviews, 2011
- A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: Altered l-serine level associated with disruption of PSAT1 gene expressionNeuroscience Research, 2011
- A Disease-causing Mutation in the Active Site of Serine Palmitoyltransferase Causes Catalytic PromiscuityOnline Journal of Public Health Informatics, 2010
- Corpus Callosum Abnormalities and Their Association with Psychotic Symptoms in Patients with SchizophreniaBiological Psychiatry, 2010
- Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids*Journal of Biological Chemistry, 2010
- Ceramide Synthase Inhibition by Fumonisin B1 Causes Accumulation of 1-DeoxysphinganineOnline Journal of Public Health Informatics, 2009
- Regulation and functions of sphingosine kinases in the brainBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Evidence for disruption of sphingolipid metabolism in schizophreniaJournal of Neuroscience Research, 2008
- Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: Analysis of the National Brain Databank microarray collectionSchizophrenia Research, 2008
- Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolarsProceedings of the National Academy of Sciences of the United States of America, 2007